Azelaic acid 15% gel

آزلائیک اسید ژل ۱۵٪

⚠ Unverified

🧴 DermatologicalsTopical anti-rosacea

Market / country: 🇺🇸 USA

Finacea (US)

🧮 Dose calculator

Rosacea · Regimen source: FDA Azelaic acid 15% · 2

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Warnings

Formulations

👥 Special populations

  • 🤰 PregnancyNo specific problem stated

    Label: minimal systemic absorption; fetal exposure not expected. FDA Azelaic acid 15% · 8.1

    “Risk Summary Azelaic acid is minimally absorbed systemically following topical route of administration, and maternal use is not expected to result in fetal exposure to the drug [ see Clinical Pharmacology (12.3) ].”
  • 🤱 BreastfeedingNo specific problem stated

    Label: infant exposure not expected. FDA Azelaic acid 15% · 8.2

    “… elevant amounts to cause a change in azelaic acid concentration in milk or milk production; therefore, breastfeeding is not expected to result in exposure of the infant to Azelaic Acid Gel, 15%.”
  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Azelaic acid 15% · 8.4

    “The safety and effectiveness of Azelaic Acid Gel, 15% have not been established in pediatric patients.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Azelaic acid 15% · 8.5

    “Clinical studies of Azelaic Acid Gel, 15% did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects.”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav